Gloria Ortega-Pérez. MD Anderson Cancer Center Madrid – Hospiten. Madrid, Spain
Francisco Javier Lacueva. Universidad Miguel Hernández. Elx. Alacant, Spain

• Preoperative frailty predicts functional recovery and quality of life outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
  Daniel Steffens. Royal Prince Alfred Hospital / The University of Sydney. Camperdown, Australia
• Hyperthermic intraperitoneal chemotherapy with cytoreductive surgery improves outcomes in advanced epithelial ovarian cancer across different settings: experience from a tertiary oncology care center india
  Mukurdipi Ray. All India Institute of Medical Sciences. Delhi. New Delhi, India
• Perioneal Regression Grading Score (PRGS) improves survival prediction in patients with neoadjuvant chemotherapy for ovarian cancer
  Flurina Saner. Bern University Hospital. Bern, Switzerland
• Quality of life after complete cytoreduction for advanced ovarian carcinomatosis: first prospective experience from Morocco and Africa using the EORTC QLQ-OV28
  Amine Souadka. National Institute of Oncology Mohammed Vth University. Rabat, Morocco
• Extended surgery confers no survival benefit for low-grade appendiceal mucinous neoplasms (LAMN) with or without limited peritoneal spread: new evidence from a multicenter working group (LAMNET)
  Marcello Guaglio. IRCCS Istituto Nazionale dei Tumori. Milan, Italy
• Anesthesiologic survey on perioperative management of patients with peritoneal carcinomatosis treated by cytoreductive surgery + hipec on behalf of sico (italian society surgical oncology) – psm oncoteam.
  Marco Vaira. AOU Policlinico Di Modena. Modena, Italy
• Does open versus closed HIPEC with mitomycin C affect cytopenia rates following cytoreductive surgery?
  Prateek Arora. The Christie NHS Foundation Trust. Manchester, UK
• Overall survival post-secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal cancer with peritoneal metastases
  Raymond Hayler. St George Hospital. London, UK
• Systemic absorption of mitomycin c and cisplatin by healthcare workers participating in hyperthermic intraperitoneal chemotherapy (HIPEC) operations
  Paula Marincola Smith. MD Anderson Cancer Center. Houston, Texas